HEDIMED project has come to an end After a long journey that started in 2020, the HEDIMED project has now officially concluded. Along the way we have gained valuable new insights into the links between the exposome and immune-mediated diseases – with more still to come in the form of collaboration and upcoming publications! We…
Celiac disease, a condition where the immune system reacts abnormally to gluten, used to be considered rare. Today, it’s being diagnosed more than ever – especially in children. But this increase isn’t just due to better testing. Evidence suggests the disease itself is becoming more common, at least in certain countries (King et al. 2020)….
On Tuesday, 22nd May, the HEDIMED team hosted the projet’s final public event — a culmination of years of groundbreaking work exploring how environmental exposures influence immune-mediated diseases. The online event “Environment & Immune-mediated diseases: Exposomic insights from the HEDIMED Project – Final Stakeholder Event” brought together over 100 participants from 17 different European countries!…
A celebration of science and the years of collaboration The HEDIMED Consortium gathered for its final meeting in Siena from April 8th to 11th, bringing together leading minds in exposome research for a vibrant and inspiring event. Hosted in the stunning historical Rettorato building, the meeting was a true celebration of science, collaboration, and shared…
As HEDIMED activities are coming to a close, we want like to give you a glimpse into the future of exposome research. Firstly, we would like to indroduce the Exposome Moonshot Forum, held on May 12-15, 2025 in Washington, DC. The Forum aims to advance the Human Exposome Project, a global effort to map environmental…
Advancing the use of health data in a secure and collaborative manner is critical for driving innovation in exposome research. The European Health Data Space (EHDS) is an EU initiative designed to facilitate the secure sharing and utilization of health data for healthcare, research, and policymaking across member states. It plays a pivotal role in…
Like other immune-mediated diseases, allergic diseases have been increasing in the Western world at the same time as economic and societal development, urbanization, and Western lifestyle in general. Allergic diseases include allergic asthma, allergic rhinitis, food allergy, atopic eczema, and as a severe case anaphylaxis. The European Academy of Allergy and Clinical Immunology (EAACI) has…
From November 26th to 28th, the EHEN (European Human Exposome Network) final meeting took place in Brussels, bringing together researchers, stakeholders, and policymakers to discuss the network’s achievements and future directions. The event was divided into two-day scientific meeting followed by a one day stakeholder event, each packed with inspiring presentations and lively discussions. Two…
Novel Technologies used in HEDIMED Volatile organic compounds (VOCs) are substances that readily evaporate in our ordinary living environment. This means that they have a high vapour pressure at room temperature and low boiling point, which facilitates their volatility and makes them responsible for odours and smells. VOCs are a diverse group of compounds derived…
The annual meeting of EHEN (European Human Exposome Network) took place in Leuven 30th of May – the 1st of June. Over a hundred members of nine EHEN projects had an opportunity to communicate, network, and disseminate their research. Thank you for your work all organizing team members! It was great that online attending was…